Clinical Trial Update: A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study assessing the pharmacokinetic interaction between itraconazole and alisertib in participants with advanced solid tumors or relapsed/refractory lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Refractory Lymphoma
• Solid Tumors

Drugs mentioned

• Alisertib (alisertib)
• Itraconazole (Itraconazole)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Solid Tumors, Relapsed/Refractory Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2019-09-20